Stephen Hanauer to CD8-Positive T-Lymphocytes
This is a "connection" page, showing publications Stephen Hanauer has written about CD8-Positive T-Lymphocytes.
Connection Strength
0.015
-
A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis. Gastroenterology. 2007 Nov; 133(5):1414-22.
Score: 0.015
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.